How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?

Dig Dis Sci. 2018 Aug;63(8):2115-2121. doi: 10.1007/s10620-018-5067-7.

Abstract

Barrett's esophagus is the only known pre-cancerous lesion for esophageal adenocarcinoma and is diagnosed by high-definition white light endoscopy demonstrating a columnar-lined esophagus along with biopsy evidence of intestinal metaplasia. With accurate performance and reporting of the endoscopic procedure, an evidence-based management strategy can be developed for treatment of Barrett's dysplasia. However, cross-sectional data demonstrate that there is still inconsistency among gastroenterologists in performance and reporting of endoscopic findings in patients with Barrett's esophagus. Here, we present an evidence-based review of how to report endoscopic findings in Barrett's esophagus.

Keywords: Acetic Acid Chromoendoscopy; Barrett's Esophagus (BE); Barrett’s inspection time; Narrow Band imaging (NBI); Paris classification; Prague C and M criteria.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / etiology
  • Adenocarcinoma / pathology*
  • Barrett Esophagus / complications
  • Barrett Esophagus / pathology*
  • Esophageal Neoplasms / etiology
  • Esophageal Neoplasms / pathology*
  • Esophagoscopy* / methods
  • Esophagoscopy* / standards
  • Esophagus / pathology
  • Evidence-Based Practice
  • Humans
  • Precancerous Conditions / pathology
  • Quality Improvement
  • Research Report / standards*

Supplementary concepts

  • Adenocarcinoma Of Esophagus